ARCHIVES

Olaparib, A PARP Inhibitor, Can Reduce Tumor Size In Advanced Ovarian Cancer

This article is from The Cancer Letter archive.

Vol. 33 No. 8 | August 27, 2010

Download PDF Visit The Full Archive

Related Articles

In This Issue: The controversy Over “Cancer Undefeated”

June 6, 1997

New guidelines for Cancer Center Support Grants will enable centers to apply for salary support for clinical investigators.

October 8, 2004

Oncology Nursing Foundation Offers Research Fellowship, Clinical Scholar Award

September 29, 1995

In Brief: NCI Cutting Back Support For Training Medical, Pediatric Oncologists; Clark Receives ACS Award

December 5, 1980

Collins, Lander, Botstein Win Albany Prize.

March 12, 2010

Cancer Groups Propose Six Characteristics Of Next FDA Head.

December 19, 2008